Reconsidering harbingers of dementia: progression of parietal lobe white matter hyperintensities predicts Alzheimer's disease incidence.

PubWeight™: 1.08‹?› | Rank: Top 10%

🔗 View Article (PMID 25155654)

Published in Neurobiol Aging on July 21, 2014

Authors

Adam M Brickman1, Laura B Zahodne2, Vanessa A Guzman3, Atul Narkhede3, Irene B Meier3, Erica Y Griffith3, Frank A Provenzano3, Nicole Schupf4, Jennifer J Manly5, Yaakov Stern5, José A Luchsinger6, Richard Mayeux7

Author Affiliations

1: Taub Institute for Research on Alzheimer's Disease and the Aging Brain, College of Physicians and Surgeons, Columbia University, New York, NY, USA; Gertrude H. Sergievsky Center, College of Physicians and Surgeons, Columbia University, New York, NY, USA; Department of Neurology, College of Physicians and Surgeons, Columbia University, New York, NY, USA. Electronic address: amb2139@columbia.edu.
2: Taub Institute for Research on Alzheimer's Disease and the Aging Brain, College of Physicians and Surgeons, Columbia University, New York, NY, USA; Department of Neurology, College of Physicians and Surgeons, Columbia University, New York, NY, USA.
3: Taub Institute for Research on Alzheimer's Disease and the Aging Brain, College of Physicians and Surgeons, Columbia University, New York, NY, USA.
4: Taub Institute for Research on Alzheimer's Disease and the Aging Brain, College of Physicians and Surgeons, Columbia University, New York, NY, USA; Gertrude H. Sergievsky Center, College of Physicians and Surgeons, Columbia University, New York, NY, USA; Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY, USA.
5: Taub Institute for Research on Alzheimer's Disease and the Aging Brain, College of Physicians and Surgeons, Columbia University, New York, NY, USA; Gertrude H. Sergievsky Center, College of Physicians and Surgeons, Columbia University, New York, NY, USA; Department of Neurology, College of Physicians and Surgeons, Columbia University, New York, NY, USA.
6: Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY, USA; Department of Medicine, College of Physicians and Surgeons, Columbia University, New York, NY, USA.
7: Taub Institute for Research on Alzheimer's Disease and the Aging Brain, College of Physicians and Surgeons, Columbia University, New York, NY, USA; Gertrude H. Sergievsky Center, College of Physicians and Surgeons, Columbia University, New York, NY, USA; Department of Neurology, College of Physicians and Surgeons, Columbia University, New York, NY, USA; Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY, USA.

Articles citing this

Mediterranean diet and brain structure in a multiethnic elderly cohort. Neurology (2015) 1.53

Mild cognitive impairment, poor episodic memory, and late-life depression are associated with cerebral cortical thinning and increased white matter hyperintensities. Front Aging Neurosci (2014) 0.87

The effect of white matter hyperintensities on neurodegeneration in mild cognitive impairment. Alzheimers Dement (2015) 0.85

Cerebral autoregulation, beta amyloid, and white matter hyperintensities are interrelated. Neurosci Lett (2015) 0.83

White matter hyperintensities are a core feature of Alzheimer's disease: Evidence from the dominantly inherited Alzheimer network. Ann Neurol (2016) 0.82

Deferoxamine, Cerebrovascular Hemodynamics, and Vascular Aging: Potential Role for Hypoxia-Inducible Transcription Factor-1-Regulated Pathways. Stroke (2015) 0.82

Correlating Cognitive Decline with White Matter Lesion and Brain Atrophy Magnetic Resonance Imaging Measurements in Alzheimer's Disease. J Alzheimers Dis (2015) 0.81

Longitudinal change of small-vessel disease-related brain abnormalities. J Cereb Blood Flow Metab (2016) 0.80

White matter hyperintensities and imaging patterns of brain ageing in the general population. Brain (2016) 0.79

Peripheral (deep) but not periventricular MRI white matter hyperintensities are increased in clinical vascular dementia compared to Alzheimer's disease. Brain Behav (2016) 0.77

Late-life memory trajectories in relation to incident dementia and regional brain atrophy. J Neurol (2015) 0.77

White matter integrity as a mediator in the relationship between dietary nutrients and cognition in the elderly. Ann Neurol (2016) 0.77

Daytime Sleepiness and Sleep Inadequacy as Risk Factors for Dementia. Dement Geriatr Cogn Dis Extra (2015) 0.77

Gender differences in white matter pathology and mitochondrial dysfunction in Alzheimer's disease with cerebrovascular disease. Mol Brain (2016) 0.76

Preclinical Cerebral Network Connectivity Evidence of Deficits in Mild White Matter Lesions. Front Aging Neurosci (2016) 0.76

Sleep Duration and White Matter Quality in Middle-Aged Adults. Sleep (2016) 0.76

APOE ɛ2 is associated with white matter hyperintensity volume in CADASIL. J Cereb Blood Flow Metab (2016) 0.76

Differential Regional Distribution of Juxtacortical White Matter Signal Abnormalities in Aging and Alzheimer's Disease. J Alzheimers Dis (2017) 0.76

Sleep Disordered Breathing and White Matter Hyperintensities in Community-Dwelling Elders. Sleep (2016) 0.75

Ex vivo MRI transverse relaxation in community based older persons with and without Alzheimer's dementia. Behav Brain Res (2016) 0.75

Structural MR Imaging in the Diagnosis of Alzheimer's Disease and Other Neurodegenerative Dementia: Current Imaging Approach and Future Perspectives. Korean J Radiol (2016) 0.75

A Systematic Review of Longitudinal Studies Which Measure Alzheimer's Disease Biomarkers. J Alzheimers Dis (2017) 0.75

White matter signal abnormalities in former National Football League players. Alzheimers Dement (Amst) (2017) 0.75

Articles cited by this

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology (1984) 119.59

Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol (1991) 49.03

Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology (1993) 16.92

Frequent amyloid deposition without significant cognitive impairment among the elderly. Arch Neurol (2008) 7.95

Incidence of AD in African-Americans, Caribbean Hispanics, and Caucasians in northern Manhattan. Neurology (2001) 5.98

Fibrillar amyloid-beta burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease. Proc Natl Acad Sci U S A (2009) 5.55

The cortical signature of Alzheimer's disease: regionally specific cortical thinning relates to symptom severity in very mild to mild AD dementia and is detectable in asymptomatic amyloid-positive individuals. Cereb Cortex (2008) 5.36

Latent variable modeling of differences and changes with longitudinal data. Annu Rev Psychol (2009) 4.87

Diagnosis of dementia in a heterogeneous population. Development of a neuropsychological paradigm-based diagnosis of dementia and quantified correction for the effects of education. Arch Neurol (1992) 4.63

A pathophysiological framework of hippocampal dysfunction in ageing and disease. Nat Rev Neurosci (2011) 3.23

Extent and distribution of white matter hyperintensities in normal aging, MCI, and AD. Neurology (2006) 3.22

Evolution of the neuropathology of Alzheimer's disease. Acta Neurol Scand Suppl (1996) 3.02

PIB is a non-specific imaging marker of amyloid-beta (Abeta) peptide-related cerebral amyloidosis. Brain (2007) 2.88

Cerebral amyloid angiopathy: incidence and complications in the aging brain. II. The distribution of amyloid vascular changes. Stroke (1984) 2.86

MRI correlates of neurofibrillary tangle pathology at autopsy: a voxel-based morphometry study. Neurology (2008) 2.69

Brain morphology in older African Americans, Caribbean Hispanics, and whites from northern Manhattan. Arch Neurol (2008) 2.69

Molecular drivers and cortical spread of lateral entorhinal cortex dysfunction in preclinical Alzheimer's disease. Nat Neurosci (2013) 2.26

Longitudinal study of blood pressure and white matter hyperintensities: the EVA MRI Cohort. Neurology (2001) 2.18

Report of the second dementia with Lewy body international workshop: diagnosis and treatment. Consortium on Dementia with Lewy Bodies. Neurology (1999) 2.00

Longitudinal changes in white matter disease and cognition in the first year of the Alzheimer disease neuroimaging initiative. Arch Neurol (2010) 1.94

Long-term blood pressure fluctuation and cerebrovascular disease in an elderly cohort. Arch Neurol (2010) 1.80

Trajectory of white matter hyperintensity burden preceding mild cognitive impairment. Neurology (2012) 1.66

Measuring cerebral atrophy and white matter hyperintensity burden to predict the rate of cognitive decline in Alzheimer disease. Arch Neurol (2008) 1.48

Cerebrovascular atherosclerosis correlates with Alzheimer pathology in neurodegenerative dementias. Brain (2012) 1.47

White matter hyperintensities and cerebral amyloidosis: necessary and sufficient for clinical expression of Alzheimer disease? JAMA Neurol (2013) 1.47

Regional white matter hyperintensity volume, not hippocampal atrophy, predicts incident Alzheimer disease in the community. Arch Neurol (2012) 1.44

Structural neuroimaging in Altheimer's disease: do white matter hyperintensities matter? Dialogues Clin Neurosci (2009) 1.38

Do neuropsychological tests have the same meaning in Spanish speakers as they do in English speakers? Neuropsychology (2010) 1.37

Vascular burden and Alzheimer disease pathologic progression. Neurology (2012) 1.31

Neuropathologic basis of white matter hyperintensity accumulation with advanced age. Neurology (2013) 1.29

Subclinical cerebrovascular disease in mild cognitive impairment. Neurology (2009) 1.28

Coevolution of white matter hyperintensities and cognition in the elderly. Neurology (2012) 1.28

Comparison of gray matter and metabolic reduction in mild Alzheimer's disease using FDG-PET and voxel-based morphometric MR studies. Eur J Nucl Med Mol Imaging (2005) 1.27

Quantitative approaches for assessment of white matter hyperintensities in elderly populations. Psychiatry Res (2011) 1.22

Frontal lobe white matter hyperintensities and neurofibrillary pathology in the oldest old. Neurology (2010) 1.22

Plasma homocysteine levels, cerebrovascular risk factors, and cerebral white matter changes (leukoaraiosis) in patients with Alzheimer disease. Arch Neurol (2002) 1.17

White matter hyperintensities are significantly associated with cortical atrophy in Alzheimer's disease. J Neurol Neurosurg Psychiatry (2004) 1.16

Brain function and cognition in a community sample of elderly Latinos. Neurology (2002) 1.05

Contemplating Alzheimer's disease and the contribution of white matter hyperintensities. Curr Neurol Neurosci Rep (2013) 1.02

White matter predictors of cognitive functioning in older adults. J Int Neuropsychol Soc (2012) 0.98

Cerebral small vessel disease in aging and Alzheimer's disease: a comparative study using MRI and SPECT. Eur J Neurol (2012) 0.91

Regional white matter hyperintensity volume and cognition predict death in a multiethnic community cohort of older adults. J Am Geriatr Soc (2013) 0.78